Celularity (CELU) on Thursday said it has received written confirmation from Nasdaq that the company has regained compliance with listing rules, which require timely filing of periodic financial reports with the U.S.
Securities and Exchange Commission. – Nasdaqâs determination follows Celularityâs October 20, 2026, filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2026
Nasdaq confirmed that the reporting deficiency matter is now closed